NCT07582029

Brief Summary

Laparoscopic cholecystectomy is associated with significant postoperative pain originating from trocar sites, pneumoperitoneum, and visceral irritation. Both local anesthetic infiltration and ultrasound-guided rectus sheath block are commonly used regional analgesic techniques to reduce postoperative pain and opioid consumption. This prospective randomized controlled study aims to compare the effects of these two techniques on postoperative pain scores, opioid requirements, and analgesia-related adverse effects following laparoscopic cholecystectomy.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started May 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress5%
May 2026Dec 2026

First Submitted

Initial submission to the registry

May 6, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 12, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

May 12, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 12, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2026

Last Updated

May 12, 2026

Status Verified

May 1, 2026

Enrollment Period

6 months

First QC Date

May 6, 2026

Last Update Submit

May 6, 2026

Conditions

Keywords

Cholecystectomy, LaparoscopicRectus Sheath BlockAnesthesia, LocalPain, Postoperative

Outcome Measures

Primary Outcomes (1)

  • NRS Score

    Postoperative pain assessment will be performed using the Numeric Rating Scale (NRS). The NRS is a scale in which patients rate their pain intensity numerically from 0 (no pain) to 10 (worst imaginable pain).

    Pain scores will be assessed and recorded at postoperative 0, 1, 4, 12, and 24 hours.

Secondary Outcomes (2)

  • Opioid Consumption

    24 hour

  • Adverse Effects

    24 hour

Study Arms (2)

GROUP RSB

ACTIVE COMPARATOR

Rectus Sheath Block: After completion of the operation, during the surgical closure phase, bilateral rectus sheath block will be performed. A linear ultrasound probe will be placed transversely over the umbilicus and 1 cm lateral to it. After visualization of the rectus abdominis muscle and posterior rectus sheath, a 22-Gauge 80 mm block needle (Braun Stimuplex Ultra-360, Melsungen, Germany) will be advanced from lateral to medial using the in-plane technique. Following hydrodissection with 1 mL saline between the rectus muscle and posterior sheath and confirmation of appropriate spread, 20 mL local anesthetic (0.25% bupivacaine) will be administered with intermittent negative aspiration.

Procedure: Rectus Sheath Block

GROUP LAI

ACTIVE COMPARATOR

Local Anesthetic Infiltration: At the end of the operation, the surgeon will infiltrate 5 mL local anesthetic (0.5% bupivacaine) subcutaneously into each of the four trocar insertion sites.

Procedure: Local Anesthetic Infiltration

Interventions

At the end of the operation, the surgeon will infiltrate 5 mL local anesthetic (0.5% bupivacaine) subcutaneously into each of the four trocar insertion sites.

GROUP LAI

After completion of the operation, during the surgical closure phase, bilateral rectus sheath block will be performed. A linear ultrasound probe will be placed transversely over the umbilicus and 1 cm lateral to it. After visualization of the rectus abdominis muscle and posterior rectus sheath, a 22-Gauge 80 mm block needle (Braun Stimuplex Ultra-360, Melsungen, Germany) will be advanced from lateral to medial using the in-plane technique. Following hydrodissection with 1 mL saline between the rectus muscle and posterior sheath and confirmation of appropriate spread, 20 mL local anesthetic (0.25% bupivacaine) will be administered with intermittent negative aspiration.

GROUP RSB

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA (American Society of Anesthesiologists) class I-II patients
  • Patients aged between 18 and 65 years
  • Patients undergoing laparoscopic cholecystectomy surgery

You may not qualify if:

  • ASA class III-IV patients
  • Patients undergoing emergency surgery
  • Relatives of patients who do not provide consent
  • Presence of chronic pain
  • Chronic opioid use
  • Presence of local anesthetic allergy
  • Ibuprofen allergy
  • Paracetamol allergy
  • Presence of infection at the block site
  • Coagulopathy
  • Increased intracranial pressure
  • Pre-existing neurological deficit
  • Severe organ failure
  • Mental retardation
  • Anatomical deformity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sisli Hamidiye Etfal Training Hospital

Istanbul, 34371, Turkey (Türkiye)

Location

MeSH Terms

Conditions

CholelithiasisCholecystitisPain, Postoperative

Condition Hierarchy (Ancestors)

Biliary Tract DiseasesDigestive System DiseasesGallbladder DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • LEYLA KILINC

    şişli etfal eğitim araştırma hastanesi

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

May 6, 2026

First Posted

May 12, 2026

Study Start

May 12, 2026

Primary Completion (Estimated)

November 12, 2026

Study Completion (Estimated)

December 12, 2026

Last Updated

May 12, 2026

Record last verified: 2026-05

Locations